148 related articles for article (PubMed ID: 19212691)
21. Inhibitory effect of tellimagrandin I on chemically induced differentiation of human leukemia K562 cells.
Yi Z; Wang Z; Li H; Liu M
Toxicol Lett; 2004 Mar; 147(2):109-19. PubMed ID: 14757314
[TBL] [Abstract][Full Text] [Related]
22. Functional regulation of pre-B-cell leukemia homeobox interacting protein 1 (PBXIP1/HPIP) in erythroid differentiation.
Manavathi B; Lo D; Bugide S; Dey O; Imren S; Weiss MJ; Humphries RK
J Biol Chem; 2012 Feb; 287(8):5600-14. PubMed ID: 22187427
[TBL] [Abstract][Full Text] [Related]
23. [Effect of MiR-451a on Erythroid Differentiation of K562 Cells under Hypoxia].
Hu CY; Zhang HJ; Fu CB; Liu F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):2071-2078. PubMed ID: 33283744
[TBL] [Abstract][Full Text] [Related]
24. The role of DNA methylation in catechol-enhanced erythroid differentiation of K562 cells.
Li XF; Wu XR; Xue M; Wang Y; Wang J; Li Y; Suriguga ; Zhang GY; Yi ZC
Toxicol Appl Pharmacol; 2012 Nov; 265(1):43-50. PubMed ID: 23022512
[TBL] [Abstract][Full Text] [Related]
25. Smad2/3-pathway ligand trap luspatercept enhances erythroid differentiation in murine β-thalassaemia by increasing GATA-1 availability.
Martinez PA; Li R; Ramanathan HN; Bhasin M; Pearsall RS; Kumar R; Suragani RNVS
J Cell Mol Med; 2020 Jun; 24(11):6162-6177. PubMed ID: 32351032
[TBL] [Abstract][Full Text] [Related]
26. The role of GATA switch in benzene metabolite hydroquinone inhibiting erythroid differentiation in K562 cells.
Yu CH; Yang SQ; Zhang YJ; Rong L; Yi ZC
Arch Toxicol; 2023 Aug; 97(8):2169-2181. PubMed ID: 37329354
[TBL] [Abstract][Full Text] [Related]
27. Accumulation of gamma-globin mRNA and induction of irreversible erythroid differentiation after treatment of CML cell line K562 with new doxorubicin derivatives.
Szulawska A; Arkusinska J; Czyz M
Biochem Pharmacol; 2007 Jan; 73(2):175-84. PubMed ID: 17097070
[TBL] [Abstract][Full Text] [Related]
28. Antagonism of FOG-1 and GATA factors in fate choice for the mast cell lineage.
Cantor AB; Iwasaki H; Arinobu Y; Moran TB; Shigematsu H; Sullivan MR; Akashi K; Orkin SH
J Exp Med; 2008 Mar; 205(3):611-24. PubMed ID: 18299398
[TBL] [Abstract][Full Text] [Related]
29. Ferritin Heavy Subunit Silencing Blocks the Erythroid Commitment of K562 Cells via miR-150 up-Regulation and GATA-1 Repression.
Zolea F; Battaglia AM; Chiarella E; Malanga D; De Marco C; Bond HM; Morrone G; Costanzo F; Biamonte F
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29039805
[TBL] [Abstract][Full Text] [Related]
30. Role of transcriptional corepressor ETO2 in erythroid cells.
Fujiwara T; Alqadi YW; Okitsu Y; Fukuhara N; Onishi Y; Ishizawa K; Harigae H
Exp Hematol; 2013 Mar; 41(3):303-15.e1. PubMed ID: 23127762
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of mouse GATA-1 function by the glucocorticoid receptor: possible mechanism of steroid inhibition of erythroleukemia cell differentiation.
Chang TJ; Scher BM; Waxman S; Scher W
Mol Endocrinol; 1993 Apr; 7(4):528-42. PubMed ID: 8502237
[TBL] [Abstract][Full Text] [Related]
32. Effects of miR‑210‑3p on the erythroid differentiation of K562 cells under hypoxia.
Hu C; Yan Y; Fu C; Ding J; Li T; Wang S; Fang L
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34109429
[TBL] [Abstract][Full Text] [Related]
33. c-FLIP is involved in erythropoietin-mediated protection of erythroid-differentiated cells from TNF-alpha-induced apoptosis.
Vittori D; Vota D; Callero M; Chamorro ME; Nesse A
Cell Biol Int; 2010 May; 34(6):621-30. PubMed ID: 20218968
[TBL] [Abstract][Full Text] [Related]
34. Valproic acid regulates erythro-megakaryocytic differentiation through the modulation of transcription factors and microRNA regulatory micro-networks.
Trécul A; Morceau F; Gaigneaux A; Schnekenburger M; Dicato M; Diederich M
Biochem Pharmacol; 2014 Nov; 92(2):299-311. PubMed ID: 25241289
[TBL] [Abstract][Full Text] [Related]
35. GATA-1 forms distinct activating and repressive complexes in erythroid cells.
Rodriguez P; Bonte E; Krijgsveld J; Kolodziej KE; Guyot B; Heck AJ; Vyas P; de Boer E; Grosveld F; Strouboulis J
EMBO J; 2005 Jul; 24(13):2354-66. PubMed ID: 15920471
[TBL] [Abstract][Full Text] [Related]
36. FOG-1 represses GATA-1-dependent FcepsilonRI beta-chain transcription: transcriptional mechanism of mast-cell-specific gene expression in mice.
Maeda K; Nishiyama C; Tokura T; Nakano H; Kanada S; Nishiyama M; Okumura K; Ogawa H
Blood; 2006 Jul; 108(1):262-9. PubMed ID: 16522818
[TBL] [Abstract][Full Text] [Related]
37. Isolation and characterization of hematopoietic transcription factor complexes by in vivo biotinylation tagging and mass spectrometry.
Grosveld F; Rodriguez P; Meier N; Krpic S; Pourfarzad F; Papadopoulos P; Kolodziej K; Patrinos GP; Hostert A; Strouboulis J
Ann N Y Acad Sci; 2005; 1054():55-67. PubMed ID: 16339652
[TBL] [Abstract][Full Text] [Related]
38. GATA-1 binding sites in exon 1 direct erythroid-specific transcription of PPOX.
de Vooght KM; van Wijk R; van Solinge WW
Gene; 2008 Feb; 409(1-2):83-91. PubMed ID: 18191920
[TBL] [Abstract][Full Text] [Related]
39. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
40. Elucidation of the role of LMO2 in human erythroid cells.
Inoue A; Fujiwara T; Okitsu Y; Katsuoka Y; Fukuhara N; Onishi Y; Ishizawa K; Harigae H
Exp Hematol; 2013 Dec; 41(12):1062-76.e1. PubMed ID: 24041784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
